Durham, N.C.
Eli Lilly & Company is planning to build a $474 million pharmaceutical manufacturing center in Durham, N.C. Located in Research Triangle Park, the next-generation facility will produce injectable therapeutics and delivery devices for conditions such as Type 2 diabetes. Accommodating over 450 new employees, the project will provide integrated manufacturing, engineering, and warehouse areas. Operations will commence at the site in 2023.
Source
